Premji Invest is targeting two separate transactions in the aerospace and defence hardware space alongside prominent co-investors. The firm is partnering with Singularity AMC to lead an investment into defence electronics manufacturer Sanlayan Technologies. Additionally, Premji Invest and TVS Capital are in advanced discussions to anchor the first institutional capital raise for aerospace parts producer Hical Technologies. These combined transactions reflect an aggressive push to finance high-precision domestic manufacturing capabilities.
Key points
The planned capital infusions represent a deliberate strategic focus by Premji Invest on…: The planned capital infusions represent a deliberate strategic focus by Premji Invest on deeptech and advanced manufacturing enterprises.
Hical Technologies is set to secure between $30 million and $40 million in its first inst…: Hical Technologies is set to secure between $30 million and $40 million in its first institutional funding round.
Major investment firms are teaming up through co-led consortiums to deploy capital into B…: Major investment firms are teaming up through co-led consortiums to deploy capital into Bengaluru-based strategic technology companies.
Sources checked by our analysis pipeline: 1
Bengaluru: Premji Invest has held discussions to back Bengaluru-based defence electronics maker Sanlayan Technologies and aerospace components manufacturer Hical Technologies, marking an intensification of the private investment firm’s bets on strategic manufacturing and deeptech companies, people familiar with the development said.Premji Invest and Singularity AMC are likely to lead a $30-40 million round in Sanlayan at a valuation of about
Premji Invest goes big on strategic output & tech
Synopsis
Premji Invest and Singularity AMC are likely to lead a $30-40 million round in Sanlayan at a valuation of about $200 million, according to the people. Separately, Premji Invest is in advanced talks to lead Hical’s first institutional funding round of $30-40 million, alongside TVS Capital.
Raw material markets are increasingly diverging as individual sector fundamentals and geopolitical tensions eclipse traditional cross-commodity correlations. To navigate this landscape, Tata Asset Management recommends balancing defensive safe havens with industrial assets leveraged to global technological shifts. This portfolio approach positions investors to absorb macroeconomic headwinds while securing exposure to long-term structural supply deficits.
The pharmaceutical firm approved the significant interim distribution during its late-October board meeting, establishing early November eligibility deadlines for shareholders. This substantial cash reward offers immediate yields to investors seeking current income amid a challenging environment. However, the generous capital return comes against a backdrop of prolonged, multi-year share price declines for the drugmaker.
Investors are pausing their recent buying momentum as global financial conditions face potential shifts stemming from Washington's political landscape. Potential adjustments to American fiscal policies and fluctuating energy markets threaten to reverse recent progress across domestic bourses. Consequently, elevated commodity prices are adding pressure to local trading sentiment ahead of the legislative results.